Oxeco PLC Stock London S.E.
Equities
OXE
GB00B1J5QT30
Advanced Medical Equipment & Technology
End-of-day quote
Other stock markets
|
||
- GBX | - |
Mar. 19 | Tissue Regenix annual loss narrows sharply as revenue jumps | AN |
Mar. 19 | Earnings Flash (TRX.L) TISSUE REGENIX GROUP Reports FY23 Revenue $29.5M | MT |
Sales 2024 * | 27.11M 33.89M | Sales 2025 * | 31.03M 38.8M | Capitalization | 43.3M 54.13M |
---|---|---|---|---|---|
Net income 2024 * | - 0 | Net income 2025 * | - 0 | EV / Sales 2024 * | 1.69 x |
Net Debt 2024 * | 2.62M 3.28M | Net Debt 2025 * | 3.84M 4.8M | EV / Sales 2025 * | 1.52 x |
P/E ratio 2024 * |
-366
x | P/E ratio 2025 * |
147
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 53.25% |
Managers | Title | Age | Since |
---|---|---|---|
Daniel Lee
CEO | Chief Executive Officer | 63 | 18-12-31 |
Kirsten Lund
DFI | Director of Finance/CFO | - | 09-12-31 |
David Cocke
DFI | Director of Finance/CFO | 58 | 21-01-20 |
Members of the board | Title | Age | Since |
---|---|---|---|
Trevor Phillips
BRD | Director/Board Member | 63 | 21-01-04 |
George Phillips
BRD | Director/Board Member | 64 | 21-01-04 |
Daniel Lee
CEO | Chief Executive Officer | 63 | 18-12-31 |
1st Jan change | Capi. | |
---|---|---|
+3.41% | 32.41B | |
+13.11% | 7.31B | |
+20.38% | 3.85B | |
-14.26% | 3.33B | |
-27.90% | 1.26B | |
-34.43% | 1.12B | |
+2.01% | 932M | |
-24.21% | 864M | |
-38.47% | 863M |
- Stock Market
- Equities
- TRX Stock
- OXE Stock